Recent Posts in Dangerous Drugs Category
61 results found. Viewing page 1 of 3.
Go to page
Posted on May 16, 2012 By Pharmaceutical Injury Attorney
David Brennan, CEO of AstraZeneca, is leaving his position following a dramatic drop in the company's performance. Investors have recently become discontent with the performance of the company. ...
Continue reading "AstraZeneca CEO Steps Down as Earnings Fall" »
Posted on May 14, 2012 By Pharmaceutical Injury Lawyer
Ongoing studies have been taking place to determine just how dangerous the drug Pradaxa is. Pradaxa is a drug that is prescribed to patients to treat blood clots and prevent strokes. Patients started ...
Continue reading "New Research Says Pradaxa More Dangerous Than Warfarin" »
Posted on May 11, 2012 By Medical Injury Attorney
Abbott Laboratories has agreed to pay $1.6 billion in fines to state and federal governments for illegally promoting unapproved uses of its anti-seizure drug Depakote. At specific issue was the ...
Continue reading "Depakote Makers Pay $1.6 Billion over Illegal Drug Marketing Practices" »
Posted on May 10, 2012 By Medical Injury Attorney
Existing policies by the Food and Drug Administration (FDA) allow "accelerated approval" of some developing drugs. "Accelerated approval" lets the FDA approve drugs in phase II of ...
Continue reading "Debate over FDA "Conditional Approval" of New Drugs" »
Posted on May 9, 2012 By Pharmaceutical Injury Lawyer
Federal judge Rebecca Doherty who is overseeing the Actos drug injury multidistrict litigation (MDL) has recently made a decision that will make it easier for patients injured by the drug to join the ...
Continue reading "Joining an Actos MDL May Be Easier Than You Think" »
Posted on May 8, 2012 By Medical Injury Attorney
A new Food and Drug Administration (FDA) study published this week in the New England Journal of Medicine warns that women who take bone-building drugs to treat osteoporosis are at risk of developing ...
Continue reading "Long Term use of Osteoporosis Drugs may be Harmful" »
Posted on May 7, 2012 By drug Injury Attorney
Two senators have opened an investigation into financial ties between the producers of prescription painkillers and pain experts in the medical field. The Senate Finance Committee published several ...
Continue reading "Pain Experts in Unethical Relationship with Makers of Painkillers" »
Posted on May 6, 2012 By Drug Defect Lawyer
ACE (angiotensin converting enzyme) inhibitors, a class of drug used to lower blood pressure, work by blocking the formation of angiotensin II, a potent chemical that narrows blood vessels, raising ...
Continue reading "New Concern Over Severe Side Effect of Blood Pressure Drug" »
Posted on May 3, 2012 By Pharmaceutical Injury Lawyer
After any assessed risk with a product, the FDA will then intervene in some way. This may take on a number of different forms. One thing they will do is regulate product labeling. Products such as ...
Continue reading "How the FDA Intervenes" »
Posted on May 3, 2012 By Drug Injuries Lawyer
Public Citizen, a consumer safety advocate group, petitioned the Food and Drug Administration (FDA) last week to recall the diabetes drug Victoza because of the dangerous side effects it can cause in ...
Continue reading "Consumer Group Urges Recall of Dangerous Drug" »
Posted on May 2, 2012 By Pharmaceutical Injury Attorney
The Food and Drug Administration has a process by which they assess and manage the possible risk of products. This goes for products that are both on the market and those that have not yet entered the ...
Continue reading "How the FDA Assesses Risk" »
Posted on May 1, 2012 By Drug Injury Lawyer
The Prescription Drug User Fee Act (PDUFA) of 1992 ruled that companies applying for approval of new drugs or medical devices would be required to pay a user fee to the Food and Drug Administration ...
Continue reading "Exploring the Debate Over FDA User Fees" »
Posted on Apr 30, 2012 By Dangerous Drug Lawyer
A New Haven jury has ruled that drug maker Pfizer must pay a woman at least $4 million in damages because she developed breast cancer after taking Prempro, the company's menopause drug. The jury ...
Continue reading "Pfizer Must Pay Damages for Dangerous Drug" »
Posted on Apr 26, 2012 By Pharmaceutical Injury Attorney
A $64 million class-action settlement has officially received the OK which means that parents of children who took the antidepressant can start receiving reimbursements. The suit was based upon the ...
Continue reading "Paxil Settlement Reaches $64 Million" »
Posted on Apr 20, 2012 By Drug Injury Attorney
In a suit filed by the state of Arkansas, a jury found Johnson & Johnson guilty of hiding the risks associated with the antipsychotic drug Risperdal. Risperdal is a "second generation" ...
Continue reading "Johnson & Johnson Fined for Hiding Drug Risks" »
Posted on Apr 19, 2012 By Medical Injury Attorney
A new bill introduced in both the House and the Senate this week sought to allow generic drug companies to independently update warning information on their labels. Currently, generic drug makers are ...
Continue reading "New Bills Seek to Change Rules on Generic Drug Label Updates" »
Posted on Apr 18, 2012 By Pharmaceutical Injury Lawyer
The U.S. Supreme Court ruled in favor of Sun Pharmaceutical Industries in a patent litigation case over Repaglinide tablets (brand name: Prandin). Repaglinide is a drug prescribed to those suffering ...
Continue reading "Court Rules In Favor of Sun Pharma" »
Posted on Apr 17, 2012 By Pharmaceutical Injury Lawyer
Johnson & Johnson was hit with another lawsuit over a case in which a baby was killed after taking Tylenol. According to reports, an Illinois family gave their 2-month-old child infant Tylenol ...
Continue reading "Tylenol Causes Baby's Death" »
Posted on Apr 13, 2012 By Pharmaceutical Injury Attorney
Just this Wednesday in Little Rock, Arkansas, a judge fined Johnson & Johnson more than $1.1 billion. Why? According to this ruling, the company concealed the risks associated with their drug ...
Continue reading "Johnson & Johnson Fined More Than $1 Billion for Risperdal" »
Posted on Apr 13, 2012 By Pharmaceutical Injury Lawyer
The German drug-maker Bayer is prepared to pay around $110 million in settlements for more than 500 lawsuits that have come against them for their Yasmin and Yaz birth-control pills. According to all ...
Continue reading "Bayer Set to Pay $110 Million for Yaz Injuries" »
Posted on Apr 11, 2012 By Pharmaceutical Injury Attorney
Cyanocobalamin is the scientific term for vitamin B12. Some people are prescribed cyanocobalamin injections for conditions such as anemia, infections and strict vegan diets. Recently, American Regent ...
Continue reading "Recall of Some Vitamin B12 Injections" »
Posted on Apr 9, 2012 By Pharmaceutical Injury Attorney
On January 31 st of this year, the drug manufacturer Pfizer issued a nationwide recall of their drugs Lo/Ovral ®-28 and Norgestrel tablets for the possibility of inexact tablet counts or tablets ...
Continue reading "Pfizer Issues Recall for Inexact Tablet Counts" »
Posted on Apr 3, 2012 By Pharmaceutical Injury Attorney
A voluntary recall is not to be confused with a decision that is optional. A voluntary recall actually means that the product has been deemed unsafe and should no longer be on the shelves. On February ...
Continue reading "FDA Issues Voluntary Recall of RegenErect" »
Posted on Mar 30, 2012 By Drug Injury Lawyer
At a time when drug and medical device recalls are prevalent, due in part to an overly streamlined Food and Drug Administration (FDA) approval process, a group of biotech firms and patient advocates ...
Continue reading "New Bill to Speed Up Drug Approval Process" »
Posted on Mar 27, 2012 By Pharmaceutical Injury Attorney
Merck & Co., the manufacturer of products like Claritin and Lotrimin, has seen disappointing results from the testing of their new blood thinner Vorapaxar. This was the drug's second large ...
Continue reading "Merck's New Drug Gives Disappointing Results" »
61 results found. Viewing page 1 of 3.
Go to page